|
| Exchange Disseminated Time | Panacea Biotec Ltd has informed BSE that the members at the 27th Annual General Meeting (AGM) of the Company held on September 24, 2011, inter alia, have accorded to the following:
1. Adoption of the Audited Balance Sheet and Profit and Loss Account for the year ended on March 31, 2011, together with Auditors’ and Directors’ Report thereon.
2. Declaration of Dividend at the rate of 75% (i.e. Re. 0.75/- per share) on the Equity Share Capital of the Company for the financial year ended on March 31, 2011.
3. Re-appointment of Dr. A N Saksena, Mr. Sumit Jain & Mr. R L Narisimhan as Directors of the Company, liable to retire by rotation.
4. Appointment of M/s. S R Batliboi & Co., Chartered Accountants, as Auditors of the Company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions.
5. Re-appointment of Mr. Soshil Kumar Jain as Whole-time Director designated as Chairman of the Company for a period of five years w.e.f. April 01, 2011, on remuneration, terms and conditions.
6. Re-appointment of Mr. Ravinder Jain as Managing Director of the Company for a period of five years w.e.f. April 01, 2011, on remuneration, terms and conditions.
7. Re-appointment of Dr. Rajesh Jain as Joint Managing Director of the Company for a period of five years w.e.f. April 01, 2011 on remuneration, terms & conditions.
8. Re-appointment of Mr. Sandeep Jain as Joint Managing Director of the Company for a period of five years w.e.f. April 01, 2011 on remuneration, terms & conditions.
9. Authority to the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Mr. Shagun Jain, as approved by the shareholders and the Central Government from time to time, subject to necessary provisions & approvals.
10. Authority to the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Ms. Radhika Jain, as approved by the shareholders and the Central Government from time to time, subject to necessary provisions & approvals.
11. Authority to the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Ms. Shilpy Jain, as approved by the shareholders from time to time, subject to necessary provisions & approvals.
12. Authority to the Board to sanction suitable increments and / or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Mr. Ankesh Jain, as approved by the shareholders from time to time, subject to necessary provisions & approvals. |
|
|